Of patients identified as low risk by combined clinicopathological factors and GEP test, only 7.1% were SLN-positive.
The NIH has awarded a $3 million research grant to CND Life Sciences to initiate a 3-year multicenter study to evaluate the validity of a skin punch biopsy test to determine risk for Parkinson’s ...
Guardant Health (($GH)) announced an update on their ongoing clinical study. Study Overview: The SIBYL study, officially titled ‘obServation of ...
MONDAY, Oct. 27, 2025 (HealthDay News) — An already-available genetic test might spare some melanoma patients from a surgical ...
Everyday Health on MSN

What Is a Prostate Biopsy?

A prostate biopsy involves removing prostate tissue to test for cancer. Learn about types, procedure, risks, and follow-up ...